enGenes returning to Swiss Biotech Day

Vienna, Austria: – Recombinant proteins specialist CDMO enGenes Biotech GmbH (enGenes) will return to the influential Swiss Biotech Day conference in Basel, at the heart of Switzerland’s thriving cluster of life science industries and research.

The enGenes team in Basel, led by Head of Business Development, Dr. Karl Hübler, will take part in Swiss Biotech Day’s many networking activities, including one-on-one partnering meetings and its Global Village that hosts delegations from all over the world.

Leading-edge technologies

Its networking campaign will emphasize the strategic importance to biotech producers of its leading-edge upstream and downstream process development technologies and advanced proprietary and biomolecule production platforms, such as enGenes-eXpress™, -eXtra™, for enhanced protein production by expression in E. coli or by secretion , as well as -eXcite™, technology for continuous biomolecule production, and -eXpand™, for site-specific incorporation of non-canonical amino acids (NCAAs). Click here to read the full article: https://www.pharmaceutical-networking.com/engenes-returning-to-swiss-biotech-day/